Intellia Therapeutics Inc buy Raymond James
Start price
10.11.23
/
50%
€22.91
Target price
10.11.24
€53.33
Performance (%)
-31.17%
End price
11.11.24
€15.77
Summary
This prediction ended on 11.11.24 with a price of €15.77. The BUY prediction by Raymond_James for Intellia Therapeutics Inc performed very badly with a performance of -31.17%. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -6.653% | -6.653% | -40.136% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Raymond_James for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten